Indication
- Seasonal allergic rhinitis (hay fever)
- Perennial allergic rhinitis
- Allergic conjunctivitis
- Common cold symptoms (sneezing, runny nose)
- Urticaria (hives)
Dosage and Administration
Route of Administration: Oral sustained-release tablet.
Typical dose for adults and children over 12 years: 8 mg once or twice daily, depending on severity.
Children aged 6-12 years: 4 mg every 12 hours.
Elderly or those with liver or kidney impairment: Consult healthcare provider for dose adjustments.
Precautions
Avoid use in patients with known hypersensitivity to chlorpheniramine or any component of the tablet.
Caution is advised in patients with glaucoma, asthma, or urinary retention.
Use with care in patients with liver or kidney impairment.
May cause drowsiness, dizziness, or dry mouth.
Not recommended during pregnancy or breastfeeding unless prescribed by a doctor.
Contraindications
Hypersensitivity to chlorpheniramine or any excipient in the tablet.
Acute narrow-angle glaucoma.
Severe urinary retention or prostate enlargement.
Key Benefits
Prolonged Relief: Sustained-release formulation provides long-lasting relief from allergy symptoms, reducing the need for frequent dosing.
Effective for Multiple Allergies: Helps with seasonal and perennial allergic rhinitis, hives, and cold symptoms.
Convenient Dosage: Once or twice-daily dosing provides ease of use for patients.
Mild Sedation: While it may cause some drowsiness, the sustained release minimizes this effect compared to short-acting antihistamines.
Improved Symptom Control: Provides effective relief, enhancing quality of life by reducing allergy and cold-related discomfort